CRA consultants assessed whether disputed representations of bioequivalence significantly affected sales of the branded product. The evaluation included consideration of distribution channels, purchase timing, and the effect of payor control mechanisms on product uptake and sales. The case ultimately resulted in a settlement.
The data-sharing paradox: Unintended consequences of mandated data-sharing policies
In response, recent EU measures such as the Digital Markets Act (DMA) and the Data Act aim to level the playing field between platforms and their users by...